CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
13 02 2023
Historique:
received: 14 02 2022
revised: 04 07 2022
accepted: 11 07 2022
pubmed: 19 8 2022
medline: 16 2 2023
entrez: 18 8 2022
Statut: ppublish

Résumé

We describe an autosomal dominant disorder associated with loss-of-function variants in the Cell cycle associated protein 1 (CAPRIN1; MIM*601178). CAPRIN1 encodes a ubiquitous protein that regulates the transport and translation of neuronal mRNAs critical for synaptic plasticity, as well as mRNAs encoding proteins important for cell proliferation and migration in multiple cell types. We identified 12 cases with loss-of-function CAPRIN1 variants, and a neurodevelopmental phenotype characterized by language impairment/speech delay (100%), intellectual disability (83%), attention deficit hyperactivity disorder (82%) and autism spectrum disorder (67%). Affected individuals also had respiratory problems (50%), limb/skeletal anomalies (50%), developmental delay (42%) feeding difficulties (33%), seizures (33%) and ophthalmologic problems (33%). In patient-derived lymphoblasts and fibroblasts, we showed a monoallelic expression of the wild-type allele, and a reduction of the transcript and protein compatible with a half dose. To further study pathogenic mechanisms, we generated sCAPRIN1+/- human induced pluripotent stem cells via CRISPR-Cas9 mutagenesis and differentiated them into neuronal progenitor cells and cortical neurons. CAPRIN1 loss caused reduced neuronal processes, overall disruption of the neuronal organization and an increased neuronal degeneration. We also observed an alteration of mRNA translation in CAPRIN1+/- neurons, compatible with its suggested function as translational inhibitor. CAPRIN1+/- neurons also showed an impaired calcium signalling and increased oxidative stress, two mechanisms that may directly affect neuronal networks development, maintenance and function. According to what was previously observed in the mouse model, measurements of activity in CAPRIN1+/- neurons via micro-electrode arrays indicated lower spike rates and bursts, with an overall reduced activity. In conclusion, we demonstrate that CAPRIN1 haploinsufficiency causes a novel autosomal dominant neurodevelopmental disorder and identify morphological and functional alterations associated with this disorder in human neuronal models.

Identifiants

pubmed: 35979925
pii: 6650380
doi: 10.1093/brain/awac278
pmc: PMC10169411
doi:

Substances chimiques

Proteins 0
CAPRIN1 protein, human 0
Cell Cycle Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

534-548

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH129724
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH111661
Pays : United States
Organisme : European Research Council
Pays : International

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Am J Hum Genet. 2017 Feb 2;100(2):267-280
pubmed: 28132688
Acta Crystallogr D Struct Biol. 2016 Jun;72(Pt 6):718-27
pubmed: 27303792
Mol Cell Biol. 1993 Oct;13(10):6367-74
pubmed: 8413235
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Transl Psychiatry. 2013 Aug 20;3:e294
pubmed: 23962924
J Neurosci. 2010 Sep 22;30(38):12816-30
pubmed: 20861386
Free Radic Biol Med. 2011 Mar 1;50(5):624-32
pubmed: 21195169
Compr Psychiatry. 2017 Feb;73:53-60
pubmed: 27915219
Nat Neurosci. 2013 Nov;16(11):1530-6
pubmed: 23584741
Nat Genet. 2022 Sep;54(9):1320-1331
pubmed: 35982160
Elife. 2017 Nov 21;6:
pubmed: 29157358
Proteins. 2017 Mar;85(3):435-444
pubmed: 27936493
Nat Rev Mol Cell Biol. 2020 Jul;21(7):363-383
pubmed: 32231263
Oxid Med Cell Longev. 2021 Jul 22;2021:6640206
pubmed: 34336109
Cell Death Differ. 2021 Jul;28(7):2029-2044
pubmed: 34099897
Nat Med. 2019 Jan;25(1):60-64
pubmed: 30617323
Hum Mol Genet. 2014 Apr 1;23(7):1829-41
pubmed: 24242291
Nature. 2016 Aug 18;536(7616):338-43
pubmed: 27509850
Proteins. 2013 Dec;81(12):2159-66
pubmed: 23996272
Sci Rep. 2016 Feb 11;6:20775
pubmed: 26865403
Acta Neuropathol Commun. 2020 Dec 22;8(1):223
pubmed: 33353564
Neuron. 2013 Sep 18;79(6):1169-82
pubmed: 24050404
Int J Mol Sci. 2021 Feb 18;22(4):
pubmed: 33670788
Oncol Lett. 2019 Jul;18(1):15-21
pubmed: 31289466
J Neurosci. 2005 Apr 27;25(17):4420-34
pubmed: 15858068
PLoS One. 2011 Apr 22;6(4):e19052
pubmed: 21544200
Hum Mutat. 2019 Aug;40(8):1030-1038
pubmed: 31116477
Sci Rep. 2022 Feb 14;12(1):2444
pubmed: 35165318
J Mol Biol. 2018 Jul 20;430(15):2244-2248
pubmed: 29391170
Cell. 2019 Aug 8;178(4):850-866.e26
pubmed: 31398340
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Cell Stem Cell. 2019 Feb 7;24(2):318-327.e8
pubmed: 30554961
Science. 2003 Apr 4;300(5616):65-7
pubmed: 12677047
Nat Commun. 2018 Jan 22;9(1):324
pubmed: 29358734
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Structure. 2020 Sep 1;28(9):1071-1081.e3
pubmed: 32649857
AIMS Neurosci. 2020 Aug 10;7(3):299-310
pubmed: 32995487
J Biol Chem. 2006 Sep 29;281(39):29011-21
pubmed: 16849329
J Neurophysiol. 2004 Jan;91(1):239-47
pubmed: 14715719
Cell Mol Life Sci. 2022 Sep 22;79(10):526
pubmed: 36136249
J Neurosci Res. 2020 Sep;98(9):1674-1684
pubmed: 31066107
Int J Mol Sci. 2020 May 06;21(9):
pubmed: 32384730
PLoS One. 2012;7(6):e39338
pubmed: 22737234
PLoS One. 2011;6(5):e19743
pubmed: 21603572
Nat Rev Genet. 2020 Mar;21(3):137-150
pubmed: 31913361
Br J Pharmacol. 2022 Apr;179(8):1512-1524
pubmed: 33644859
Nat Rev Genet. 2011 Aug 31;12(10):683-91
pubmed: 21878961
Nat Protoc. 2017 Feb;12(2):255-278
pubmed: 28079879
Mol Cell Biol. 2007 Mar;27(6):2324-42
pubmed: 17210633
Methods Mol Biol. 2015;1254:73-85
pubmed: 25431058
EBioMedicine. 2016 Jul;9:293-305
pubmed: 27333044
Nat Methods. 2009 Apr;6(4):275-7
pubmed: 19305406

Auteurs

Lisa Pavinato (L)

Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Institute of Human Genetics, Center for Molecular Medicine Cologne, Center for Rare Diseases Cologne, University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.

Andrea Delle Vedove (A)

Institute of Human Genetics, Center for Molecular Medicine Cologne, Center for Rare Diseases Cologne, University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Institute for Genetics, University of Cologne, 50674 Cologne, Germany.

Diana Carli (D)

Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.
Pediatric Onco-Hematology, Stem Cell Transplantation and Cell Therapy Division, Regina Margherita Children's Hospital, Città Della Salute e Della Scienza di Torino, 10126 Turin, Italy.

Marta Ferrero (M)

Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Experimental Zooprophylactic Institute of Piedmont, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Silvia Carestiato (S)

Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Jennifer L Howe (JL)

The Centre for Applied Genomics, Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Emanuele Agolini (E)

Laboratory of Medical Genetics, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy.

Domenico A Coviello (DA)

Laboratory of Human Genetics, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.

Ingrid van de Laar (I)

Clinical Genetics, Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, 3015 CN, Rotterdam, The Netherlands.

Ping Yee Billie Au (PYB)

Department of Medical Genetics, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB T2N 1N4, Canada.

Eleonora Di Gregorio (E)

Medical Genetics Unit, Città della Salute e della Scienza University Hospital, 10126 Turin, Italy.

Alessandra Fabbiani (A)

Medical Genetics Unit, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.
Medical Genetics, University of Siena, 53100 Siena, Italy.
Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.

Susanna Croci (S)

Medical Genetics, University of Siena, 53100 Siena, Italy.
Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.

Maria Antonietta Mencarelli (MA)

Medical Genetics Unit, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.

Lucia P Bruno (LP)

Medical Genetics, University of Siena, 53100 Siena, Italy.
Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.

Alessandra Renieri (A)

Medical Genetics Unit, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.
Medical Genetics, University of Siena, 53100 Siena, Italy.
Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.

Danai Veltra (D)

Laboratory of Medical Genetics, School of Medicine, National & Kapodistrian University of Athens, 'Aghia Sophia' Children's Hospital, 11527 Athens, Greece.

Christalena Sofocleous (C)

Laboratory of Medical Genetics, School of Medicine, National & Kapodistrian University of Athens, 'Aghia Sophia' Children's Hospital, 11527 Athens, Greece.

Laurence Faivre (L)

Centre de référence Anomalies du Développement et Syndromes Malformatifs, Fédération Hospitalo-Universitaire TRANSLAD, CHU Dijon, 21079 Dijon, France.
UMR1231 GAD, Inserm-Université Bourgogne-Franche Comté, 21078 Dijon, France.

Benoit Mazel (B)

Centre de référence Anomalies du Développement et Syndromes Malformatifs, Fédération Hospitalo-Universitaire TRANSLAD, CHU Dijon, 21079 Dijon, France.

Hana Safraou (H)

UMR1231 GAD, Inserm-Université Bourgogne-Franche Comté, 21078 Dijon, France.
Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU TRANSLAD, CHU Dijon Bourgogne, 21000 Dijon, France.

Anne-Sophie Denommé-Pichon (AS)

UMR1231 GAD, Inserm-Université Bourgogne-Franche Comté, 21078 Dijon, France.
Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU TRANSLAD, CHU Dijon Bourgogne, 21000 Dijon, France.

Marjon A van Slegtenhorst (MA)

Clinical Genetics, Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, 3015 CN, Rotterdam, The Netherlands.

Noor Giesbertz (N)

Department of Genetics, University Medical Centre Utrecht, 3584 CX, Utrecht, The Netherlands.

Richard H van Jaarsveld (RH)

Department of Genetics, University Medical Centre Utrecht, 3584 CX, Utrecht, The Netherlands.

Anna Childers (A)

Greenwood Genetic Center, Greenville, SC 29646, USA.

R Curtis Rogers (RC)

Greenwood Genetic Center, Greenville, SC 29646, USA.

Antonio Novelli (A)

Laboratory of Medical Genetics, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy.

Silvia De Rubeis (S)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Joseph D Buxbaum (JD)

Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Stephen W Scherer (SW)

Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
McLaughlin Centre, University of Toronto, Toronto, ON M5S 1A1, Canada.

Giovanni Battista Ferrero (GB)

Department of Clinical and Biological Sciences, University of Turin, 10149 Orbassano, TO, Italy.

Brunhilde Wirth (B)

Institute of Human Genetics, Center for Molecular Medicine Cologne, Center for Rare Diseases Cologne, University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Institute for Genetics, University of Cologne, 50674 Cologne, Germany.

Alfredo Brusco (A)

Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Medical Genetics Unit, Città della Salute e della Scienza University Hospital, 10126 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH